Selective risk-adapted PSA surveillance should be considered in patients with higher-risk pathology and favorable bladder cancer outcomes following a protocol.<h4>Patient summary</h4>We studied men with prostate cancer diagnosed incidentally during bladder cancer surgery. The gene discussed is KLK3; the disease is urinary bladder cancer.